Infections à polyomavirus : Questions médicales fréquentes
Nom anglais: Polyomavirus Infections
Descriptor UI:D027601
Tree Number:C01.925.256.721
Termes MeSH sélectionnés :
Data Collection
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Infections à polyomavirus : Questions médicales les plus fréquentes",
"headline": "Infections à polyomavirus : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Infections à polyomavirus : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-21",
"dateModified": "2025-02-15",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Infections à polyomavirus"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à virus à ADN",
"url": "https://questionsmedicales.fr/mesh/D004266",
"about": {
"@type": "MedicalCondition",
"name": "Infections à virus à ADN",
"code": {
"@type": "MedicalCode",
"code": "D004266",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.256"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Infections à polyomavirus",
"alternateName": "Polyomavirus Infections",
"code": {
"@type": "MedicalCode",
"code": "D027601",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jianxin You",
"url": "https://questionsmedicales.fr/author/Jianxin%20You",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Perelman School of Medicine, University of Pennsylvania; jianyou@pennmedicine.upenn.edu."
}
},
{
"@type": "Person",
"name": "Walter J Atwood",
"url": "https://questionsmedicales.fr/author/Walter%20J%20Atwood",
"affiliation": {
"@type": "Organization",
"name": "Molecular Biology, Cell Biology and Biochemistry, Brown University, Box G-E431, Lab of Molecular Medicine, 70 Ship Street, Providence, RI 02912, USA."
}
},
{
"@type": "Person",
"name": "Wei Liu",
"url": "https://questionsmedicales.fr/author/Wei%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Perelman School of Medicine, University of Pennsylvania."
}
},
{
"@type": "Person",
"name": "Nathan A Krump",
"url": "https://questionsmedicales.fr/author/Nathan%20A%20Krump",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology, Perelman School of Medicine, University of Pennsylvania."
}
},
{
"@type": "Person",
"name": "Thurid Ahlenstiel-Grunow",
"url": "https://questionsmedicales.fr/author/Thurid%20Ahlenstiel-Grunow",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany. Ahlenstiel.Thurid@mh-hannover.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Clinical data mining: challenges, opportunities, and recommendations for translational applications.",
"datePublished": "2024-02-20",
"url": "https://questionsmedicales.fr/article/38378565",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-024-05005-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "Data augmentation for Human Activity Recognition with Generative Adversarial Networks.",
"datePublished": "2024-02-12",
"url": "https://questionsmedicales.fr/article/38345954",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1109/JBHI.2024.3364910"
}
},
{
"@type": "ScholarlyArticle",
"name": "A perspective on FAIR quality control in multiplexed imaging data processing.",
"datePublished": "2024-02-09",
"url": "https://questionsmedicales.fr/article/38405548",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fbinf.2024.1336257"
}
},
{
"@type": "ScholarlyArticle",
"name": "Automated detection of fatal cerebral haemorrhage in postmortem CT data.",
"datePublished": "2024-02-08",
"url": "https://questionsmedicales.fr/article/38329584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00414-024-03183-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "How donanemab data address the coverage with evidence development questions.",
"datePublished": "2024-02-07",
"url": "https://questionsmedicales.fr/article/38323738",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/alz.13700"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ADN",
"item": "https://questionsmedicales.fr/mesh/D004266"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections à polyomavirus",
"item": "https://questionsmedicales.fr/mesh/D027601"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Infections à polyomavirus - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Infections à polyomavirus",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Infections à polyomavirus",
"description": "Comment diagnostique-t-on une infection à polyomavirus ?\nQuels tests sont utilisés pour le polyomavirus ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on détecter le virus dans l'urine ?\nLes tests sanguins sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D027601?mesh_terms=Data+Collection&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Infections à polyomavirus",
"description": "Quels sont les symptômes courants des infections à polyomavirus ?\nLes infections peuvent-elles causer des complications ?\nY a-t-il des symptômes spécifiques chez les immunodéprimés ?\nLes symptômes varient-ils selon le type de polyomavirus ?\nPeut-on avoir des symptômes respiratoires ?",
"url": "https://questionsmedicales.fr/mesh/D027601?mesh_terms=Data+Collection&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Infections à polyomavirus",
"description": "Comment prévenir les infections à polyomavirus ?\nLes vaccins existent-ils contre le polyomavirus ?\nLes mesures d'hygiène sont-elles efficaces ?\nLes patients greffés doivent-ils être surveillés ?\nLes contacts avec des personnes infectées sont-ils risqués ?",
"url": "https://questionsmedicales.fr/mesh/D027601?mesh_terms=Data+Collection&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Infections à polyomavirus",
"description": "Quel est le traitement standard pour les infections à polyomavirus ?\nLes antiviraux sont-ils efficaces contre le polyomavirus ?\nComment gérer les complications liées au polyomavirus ?\nDes traitements préventifs existent-ils ?\nLe traitement dépend-il de l'état immunitaire ?",
"url": "https://questionsmedicales.fr/mesh/D027601?mesh_terms=Data+Collection&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Infections à polyomavirus",
"description": "Quelles sont les complications possibles des infections à polyomavirus ?\nLa néphropathie virale est-elle fréquente ?\nLes complications peuvent-elles être mortelles ?\nY a-t-il des complications neurologiques ?\nComment prévenir les complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D027601?mesh_terms=Data+Collection&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Infections à polyomavirus",
"description": "Quels sont les principaux facteurs de risque ?\nLe VIH augmente-t-il le risque d'infection ?\nLes traitements immunosuppresseurs sont-ils un risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes antécédents de greffe augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D027601?mesh_terms=Data+Collection&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une infection à polyomavirus ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests PCR pour détecter l'ADN viral dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le polyomavirus ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR et les biopsies peuvent être utilisés pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent être non spécifiques, rendant le diagnostic difficile sans tests."
}
},
{
"@type": "Question",
"name": "Peut-on détecter le virus dans l'urine ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le virus peut être détecté dans l'urine, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins peuvent aider à détecter des anticorps, mais ne sont pas toujours fiables."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des infections à polyomavirus ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections peuvent être asymptomatiques ou provoquer fièvre, fatigue et douleurs."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles causer des complications ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des complications graves comme la néphropathie virale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques chez les immunodéprimés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunodéprimés peuvent présenter des symptômes plus graves, comme des infections rénales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de polyomavirus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, différents types de polyomavirus peuvent provoquer des symptômes variés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes respiratoires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections à polyomavirus peuvent provoquer des symptômes respiratoires, bien que rares."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à polyomavirus ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'hygiène, le contrôle des infections et la surveillance des patients à risque."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils contre le polyomavirus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques contre les infections à polyomavirus."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène sont-elles efficaces ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène rigoureuses peuvent réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les patients greffés doivent-ils être surveillés ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance étroite est essentielle pour détecter précocement les infections."
}
},
{
"@type": "Question",
"name": "Les contacts avec des personnes infectées sont-ils risqués ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le risque de transmission est faible, mais il est conseillé d'éviter les contacts étroits."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour les infections à polyomavirus ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique ; la gestion des symptômes est essentielle."
}
},
{
"@type": "Question",
"name": "Les antiviraux sont-ils efficaces contre le polyomavirus ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux ne sont généralement pas efficaces contre les infections à polyomavirus."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au polyomavirus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications peut nécessiter des soins spécialisés, comme la dialyse."
}
},
{
"@type": "Question",
"name": "Des traitements préventifs existent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements préventifs peuvent être envisagés pour les patients à haut risque, comme les greffés."
}
},
{
"@type": "Question",
"name": "Le traitement dépend-il de l'état immunitaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement peut varier selon que le patient est immunocompétent ou immunodéprimé."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des infections à polyomavirus ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la néphropathie virale, la pneumonie et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La néphropathie virale est-elle fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est courante chez les patients immunodéprimés, notamment les greffés rénaux."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être mortelles ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent être graves et potentiellement mortelles, surtout chez les immunodéprimés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications neurologiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications neurologiques peuvent survenir, bien que ce soit rare."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance régulière et un traitement précoce des infections peuvent aider à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent l'immunodépression, les greffes d'organes et le VIH."
}
},
{
"@type": "Question",
"name": "Le VIH augmente-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes vivant avec le VIH sont à risque accru d'infections à polyomavirus."
}
},
{
"@type": "Question",
"name": "Les traitements immunosuppresseurs sont-ils un risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements immunosuppresseurs augmentent le risque d'infections à polyomavirus."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru en raison d'une immunité diminuée."
}
},
{
"@type": "Question",
"name": "Les antécédents de greffe augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents de greffe d'organe sont un facteur de risque majeur pour ces infections."
}
}
]
}
]
}
Clinical data mining of predictive models offers significant advantages for re-evaluating and leveraging large amounts of complex clinical real-world data and experimental comparison data for tasks su...
Currently, Human Activity Recognition (HAR) applications need a large volume of data to be able to generalize to new users and environments. However, the availability of labeled data is usually limite...
Multiplexed imaging approaches are getting increasingly adopted for imaging of large tissue areas, yielding big imaging datasets both in terms of the number of samples and the size of image data per s...
During the last years, the detection of different causes of death based on postmortem imaging findings became more and more relevant. Especially postmortem computed tomography (PMCT) as a non-invasive...
The Centers for Medicare & Medicaid Services (CMS) established a class-based National Coverage Determination (NCD) for monoclonal antibodies directed against amyloid for Alzheimer's disease (AD) with ...
Understand public comfort with the use of different data types for predictive models....
We analyzed data from a national survey of US adults (n = 1436) fielded from November to December 2021. For three categories of data (identified using factor analysis), we use descriptive statistics t...
Public comfort with data use for prediction is low. For 13 of 15 data types, most respondents were uncomfortable with that data being used for prediction. In factor analysis, 15 types of data grouped ...
Although public trust is recognized as important for the sustainable expansion of predictive tools, current policy does not reflect public concerns. Low comfort with data use for prediction should be ...
Our results provide empirical evidence on public perspectives, which are important for shaping the use of predictive models. Findings demonstrate a need for realignment of policy around the sensitivit...
A recent marine metagenomic study has revealed the existence of a novel group of viruses designated mirusviruses, which are proposed to form an evolutionary link between two realms of double-stranded ...
Mirusvirus signals detected in genomic data from eight eukaryotic supergroups.Habits of putative mirusvirus hosts not limited to marine environments.Major capsid sequences from these assemblies show n...
Understanding the dynamics of biological systems in evolving environments is a challenge due to their scale and complexity. Here, we present a computational framework for the timescale decomposition o...
Modern bird skeletons stored in the faunal collections of the Institute of Zoology of the Scientific Center of Zoology and Hydroecology NAS Armenia constitute a source material for this dataset. The o...
Metagenomics has opened new avenues for exploring the genetic potential of uncultured microorganisms, which may serve as promising sources of enzymes and natural products for industrial applications. ...